CHANGING THE WORLD BILLIONS OF CELLS ATA TIME
LIVE

Serial Number

88320219

Owner

KIADIS PHARMA NETHERLANDS B.V.

Attorney

Karen Lim

Filing Date

Feb 28, 2019

Add to watchlist:

No watchlists yet
View on USPTO

CHANGING THE WORLD BILLIONS OF CELLS ATA TIME Trademark

Serial Number: 88320219 • Registration: 6687289

CHANGING THE WORLD BILLIONS OF CELLS ATA TIME is a trademark filed by KIADIS PHARMA NETHERLANDS B.V. on February 28, 2019. The trademark is classified under Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

KIADIS PHARMA NETHERLANDS B.V. (3 trademarks)

PAASHEUVELWEG 25A
AMSTERDAM 1105 BP , NL

Entity Type: 26

CytoSen Therapeutics, Inc. (5 trademarks)

Suite 2001, Room 254
Winter Springs, FL 32708

Entity Type: 03

KIADIS PHARMA INTELLECTUAL PROPERTY B.V. (7 trademarks)

PAASHEUVELWEG 25A
AMSTERDAM 1105 BP , NL

Entity Type: 26

Trademark Details

Filing Date

February 28, 2019

Registration Date

March 29, 2022

Published for Opposition

June 18, 2019

Goods & Services

Medical testing for diagnostic or treatment purposes in the field of cancer research; medical diagnostic testing, monitoring and reporting services; medical evaluation of immuno oncological disorders, cancer, diabetes, respiratory, heart, neurological and auto immune disorders; medical monitoring services; medical diagnostic, prognostic and theranostic screening and testing services; collection and preservation of dna for medical purposes; consulting services in the nature of providing medical information; consulting services in the field of healthcare and cancer diagnoses; providing a website featuring health and healthcare information related to cancer, testing and screening; genetic testing for medical purposes; providing information in the field of cancer prevention, screening, diagnosis and treatment for medical diagnostic and treatment purposes; providing genetics assessments in the nature of genetic counseling; genetic testing for medical diagnostic purposes; genomic testing for medical diagnostic purposes; gene analysis and sequencing and dna analysis and sequencing for medical diagnostic purposes and veterinary diagnostics purposes; gene analysis and sequencing and dna analysis and sequencing for use in cancer diagnosis and treatment

Scientific and technological services, namely, scientific research, design, analysis and testing in the field of cancer evolution and new cancer therapies using natural killer cells; industrial research in the field of new pharmaceutical products and new cancer therapies; medical and veterinary research services in the nature of the manipulation of cells within a laboratory or research facility to enable natural killer cells to be used for medical or therapeutic purposes; scientific research in the development of new cancer therapies; scientific research in human and animal cell therapy; scientific research into preparations for manipulating and adapting human and animal cells; consultancy relating to all the aforesaid services; conducting research and clinical trials for others relating to the use and the engineering of natural killer cells and cancer treatment and therapy; medical and scientific research in the field of cancer treatment and diagnosis; data collection for others for research purposes, namely, the collection, testing and research of patient molecular and genomic data; collection and preservation of human and animal dna for research purposes; providing a website featuring health and healthcare information related to cancer research

Filing History

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Mar 12, 2025 ASGN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 17, 2022 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
May 17, 2022 ECDR
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
May 17, 2022 EWAF
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 17, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 17, 2022 REAP
REGISTERED-PRINCIPAL REGISTER
Mar 29, 2022 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Feb 25, 2022 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Feb 24, 2022 CNPR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 10, 2022 EXRA
STATEMENT OF USE PROCESSING COMPLETE
Feb 9, 2022 SUPC
SOU EXTENSION 5 GRANTED
Feb 9, 2022 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Feb 9, 2022 AITU
USE AMENDMENT FILED
Feb 2, 2022 IUAF
SOU EXTENSION 5 FILED
Feb 2, 2022 EXT5
SOU TEAS EXTENSION RECEIVED
Feb 2, 2022 EEXT
TEAS STATEMENT OF USE RECEIVED
Feb 2, 2022 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 5, 2021 EXRA
SOU EXTENSION 4 GRANTED
Aug 3, 2021 EX4G
SOU EXTENSION 4 FILED
Aug 3, 2021 EXT4
SOU TEAS EXTENSION RECEIVED
Aug 3, 2021 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 13, 2021 EXRA
SOU EXTENSION 3 GRANTED
Feb 11, 2021 EX3G
SOU EXTENSION 3 FILED
Feb 11, 2021 EXT3
SOU TEAS EXTENSION RECEIVED
Feb 11, 2021 EEXT
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Dec 23, 2020 ASGN
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 7, 2020 EXRA
SOU EXTENSION 2 GRANTED
Aug 5, 2020 EX2G
SOU EXTENSION 2 FILED
Aug 5, 2020 EXT2
SOU TEAS EXTENSION RECEIVED
Aug 5, 2020 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 30, 2020 EXRA
SOU EXTENSION 1 GRANTED
Jan 28, 2020 EX1G
SOU EXTENSION 1 FILED
Jan 28, 2020 EXT1
SOU TEAS EXTENSION RECEIVED
Jan 28, 2020 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Aug 13, 2019 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 18, 2019 NPUB
PUBLISHED FOR OPPOSITION
Jun 18, 2019 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 29, 2019 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 10, 2019 CNSA
ASSIGNED TO EXAMINER
May 9, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 20, 2019 NWOS
NEW APPLICATION ENTERED
Mar 4, 2019 NWAP